| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Alto Neuroscience | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $253.17M | Series C | 11/21/2023 | $50.31M | $235.65M | $4.71 | InVivium Capital, Franklin Templeton, Point72, Eli Lilly and Company, Alexandria Venture Investments, Alpha Wave Ventures, Lightswitch Capital, Alkeon Capital, WhatIf Ventures, Windham Venture Partners | ||||
 | Alveus Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $202.01M | Series A | 2/24/2026 | $197M | $290.11M | $20.00 | New Rhein Healthcare Investors, Andera Partners, Omega Funds, Sanofi Capital, Kurma Partners, Avego Management, Jeito Capital, Novo Holdings, Agent Capital, Seroba Lifesciences, Global BioAccess Fund | ||||
 | Aquant | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $148.07M | Series D-1 | 8/4/2026 | $19.96M | $41.63M | $0.43 | Undisclosed Investors | ||||
 | Archy | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $96.28M | Series C | 9/11/2026 | $50M | $278.25M | $4.98 | JMI Equity, TCV, Entree Capital, Bessemer Venture Partners, CRV, Alven Capital Partners | ||||
 | AuditBoard | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.22M | Series B-1 | 11/4/2019 | $19.94M | $303.87M | $3.56 | Undisclosed Investors | ||||
 | Be Biopharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $274.72M | Series C | 1/15/2025 | $92.62M | $154.23M | $2.90 | ARCH Venture Partners, Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Bristol Myers Squibb, Takeda Ventures, Nextech | ||||
 | Bear Robotics | Industrial Robotics | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $293.68M | Series C | 3/12/2024 | $60M | $285.67M | $7.57 | LG Electronics | ||||
 | BioAge | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $1.42B | Series D | 2/13/2024 | $170M | $440.23M | $3.42 | Sofinnova Investments, Longitude Capital, RA Capital, Cormorant Asset Management, RTW Investments, SV Health Investors, OrbiMed Advisors, Sands Capital, Pivotal bioVenture Partners, Osage University Partners, Lilly Ventures, Amgen Ventures, Andreessen Horowitz | ||||
 | Biomeme | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $18.33M | Series Seed-1 | 4/11/2022 | $5.46M | $192.57M | $5.93 | Undisclosed Investors | ||||
 | Bitwise Industries | Education E-Learning | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $82.81M | Series B-2 | 2/24/2021 | $21.29M | $413.89M | $2.89 | Kapor Capital, JPMorgan Chase, Motley Foold Ventures, ProMedica, Candide Group, GingerBread Capital, Hunt Capital Investments, Impact Assets, Libra Foundation, Plum Alley, Western Technology Investment | ||||
 | Canoe Intelligence | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $81.25M | Series C | 7/9/2024 | $36M | $312.27M | $4.45 | Goldman Sachs, F-Prime Capital, Eight Roads Ventures | ||||
 | Carlsmed | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $108.89M | Series C | 2/6/2025 | $64.72M | $245.25M | $10.74 | B Capital, U.S. Venture Partners | ||||
 | Chili Piper | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $51.16M | Series B | 4/15/2021 | $33.16M | $347.07M | $7.39 | Tiger Global Management, Base10 Partners, Gradient Ventures | ||||
 | ClearDATA | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $160.84M | Series E | 11/19/2018 | $26M | $220.91M | $0.77 | Excel Venture Management, Flare Capital Partners, HCSC Ventures, Heritage Group, HLM Venture Partners, Merck Global Health Innovation Fund | ||||
 | Coder | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $175.11M | Series C | 4/1/2026 | $90M | $382.58M | $4.40 | KKR, Qube Research & Technologies, Uncork Capital, Notable Capital, Redpoint Ventures | ||||
 | CytoVale | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $204.3M | Series D | 10/10/2024 | $101M | $333.35M | $2.77 | Sands Capital, CPP Investments, Norwest Venture Partners, Global Health Investment Corporation, Breakout Ventures, Alumni Ventures | ||||
 | Defined.ai | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $79.41M | Series B-1 | 1/7/2022 | $15M | $347.86M | $9.41 | Undisclosed Investors | ||||
 | Dewpoint | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $354.6M | Series D | 9/10/2025 | $59.12M | $136.62M | $0.23 | 120 Capital | ||||
 | Dstillery | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.9M | Series 2A | 4/17/2026 | $8.2M | $236.6M | $1.69 | Undisclosed Investors | ||||
 | EatStreet | Transportation Delivery Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.53M | Series C-3 | 10/9/2018 | $12M | $97.83M | $12.04 | Gener8tor, CSA Partners | ||||
 | EdgeQ | Technology Hardware Communications Equipment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $120.38M | Series B | 4/19/2023 | $18.04M | $318.31M | $4.06 | Phaistos Investment Fund, Strategic Development Fund, EDBI, IRONGREY, ST Engineering, Yaletown, ClearSky | ||||
 | Endgame Software | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $47.25M | Series B | 2/8/2022 | $30M | $272.47M | $13.42 | EQT Ventures, Lachy Groom, Menlo Ventures, Upfront Ventures, Unusual Ventures | ||||
 | Eridu | Technology Hardware Other Technology Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $229.91M | Series A | 3/10/2026 | $166.71M | $425.3M | $2.80 | Socratic Partners, John Doerr, Hudson River Trading, Capricorn Investment Group, Matter Venture Partners, Bosch Ventures, Eclipse Capital, Fusion Fund, Osage University Partners, SBVA, TDK Ventures, VentureTech Alliance, Zelda Ventures, Black Opal Ventures, Catapult Ventures, Chamaeleon, Fathom Fund, Friends & Family Capital, Godfrey Capital, Hyperlink Ventures, Leslie Enterprises, MediaTek, Modi Ventures, Ohio Innovation, Open Field Capital, Perkins Enterprises, Pierre Lamond, Rice Management, Struck Capital, Triple Point Capital | ||||
 | FingerprintJS | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $113.24M | Series C | 10/17/2023 | $33M | $352.17M | $7.01 | Nexus Venture Partners, Uncorrelated Ventures | ||||